MENU
+Compare
SCNI
Stock ticker: NASDAQ
AS OF
Jul 18, 04:48 PM (EDT)
Price
$2.15
Change
+$0.01 (+0.47%)
Capitalization
2.14M

SCNI Scinai Immunotherapeutics Ltd. Forecast, Technical & Fundamental Analysis

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai’s drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies... Show more

SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SCNI with price predictions
Jul 17, 2025

Momentum Indicator for SCNI turns negative, indicating new downward trend

SCNI saw its Momentum Indicator move below the 0 level on July 15, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 111 similar instances where the indicator turned negative. In of the 111 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SCNI turned negative on July 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCNI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SCNI entered a downward trend on July 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SCNI advanced for three days, in of 197 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.493) is normal, around the industry mean (17.995). P/E Ratio (1.188) is within average values for comparable stocks, (59.169). SCNI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.515). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (2.627) is also within normal values, averaging (275.695).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SCNI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCNI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SCNI is expected to report earnings to fall 3,548.28% to -10 cents per share on May 02

Scinai Immunotherapeutics Ltd. SCNI Stock Earnings Reports
Q4'22
Est.
$-0.10
Q3'22
Beat
by $0.10
Q2'22
Est.
$-0.01
Q1'22
Est.
$0.00
The last earnings report on November 30 showed earnings per share of 0 cents, beating the estimate of -10 cents. With 53.40K shares outstanding, the current market capitalization sits at 2.14M.
A.I. Advisor
published General Information

General Information

a manufacturer of the innovative flu vaccine

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Hadassah Ein Kerem Campus
Phone
+972 89302529
Employees
33
Web
https://www.biondvax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XXII4.900.32
+6.99%
22nd Century Group Inc
HTH31.350.75
+2.45%
Hilltop Holdings
RGNX8.690.19
+2.24%
REGENXBIO
GAP20.340.13
+0.64%
Gap Inc (The)
ELUT2.03N/A
N/A
Elutia

SCNI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with TAOX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-0.77%
TAOX - SCNI
73%
Closely correlated
+0.97%
SYRE - SCNI
43%
Loosely correlated
+4.26%
MBIO - SCNI
37%
Loosely correlated
+4.98%
BIVI - SCNI
34%
Loosely correlated
+10.12%
VANI - SCNI
32%
Poorly correlated
-1.85%
More